State-controlled lender Banco do Brasil sees 2020 profit up 10%

Brazilian state-controlled lender Banco do Brasil SA sees its profits likely growing 10% in 2020 from this year, its Chief Financial Officer Carlos Hamilton Araujo said on Thursday in a meeting with analysts.

PSA readying sale of its stake in Chinese tie-up with Changan

Peugeot maker PSA Group is preparing to sell its 50% stake in a joint venture with Chinese partner Chongqing Changan Automotive , a spokesman for the French carmaker said on Thursday.

World stocks stall as U.S.-China tensions flare again

A four-day rally that had lifted world stocks to near-record highs stalled on Thursday after China said it would retaliate for U.S. legislation backing Hong Kong's protesters, leaving investors concerned as to the extent of the Chinese response.

Hedge funds control 35-45% of Osram shares in headache for suitor AMS: source

Hedge funds control 35-45% of the shares of German lighting group Osram , posing a headache for Austrian suitor AMS as the investors may press for the $5 billion offer to be sweetened, a person close to the matter said on Thursday.

Exclusive: Big four auditors face investor calls for tougher climate scrutiny

European investors managing assets worth more than 1 trillion pounds ($1.28 trillion) are pressing top auditors to take urgent action on climate-related risks, warning that failure to do so could do more damage than the financial crisis.

Royal Mail union loses appeal to overturn injunction halting strike

Britain's Royal Mail on Thursday confirmed that its biggest union lost an appeal to overturn a High Court injunction to stop a strike ahead of a general election and the holiday season next month.

Permira, North Face owner among bidders for sneaker brand Golden Goose: sources

U.S. apparel and footwear conglomerate VF Corporation and buyout funds Permira and Advent are lining up indicative offers for Italian shoe brand Golden Goose ahead of a mid December deadline, sources familiar with the matter told Reuters.

Novartis's $90 million Swiss factory to help solve cell therapy bottleneck

Swiss drugmaker Novartis's new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of its cell therapy Kymriah for cancer in 2020.

Morgan Stanley dismisses traders linked to concealment of multimillion-dollar loss: Bloomberg

Morgan Stanley has fired or placed on leave at least four traders over alleged mismarking of securities that concealed losses of between $100 million and $140 million, Bloomberg reported on Thursday citing people familiar with the matter.

Canada's TMX Group says it is looking into past conduct of CEO

TMX Group is looking into allegations about the past conduct of its chief executive officer, Lou Eccleston, the operator of the Toronto Stock Exchange said in a statement.

Related Videos

Man City stake sale values soccer club at $4.8 bln

U.S. consumer confidence slips; new home sales dip

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS